93 related articles for article (PubMed ID: 29313231)
1. Relationship between Hedgehog Signaling Pathway and Drug Resistance of Poorly Differentiated Gliomas.
Cherepanov SA; Grinenko NF; Antonova OM; Kurapov PB; Shepeleva II; Chekhonin VP
Bull Exp Biol Med; 2018 Jan; 164(3):356-361. PubMed ID: 29313231
[TBL] [Abstract][Full Text] [Related]
2. Effect of Hedgehog Signaling Pathway Activation on Proliferation of High-Grade Gliomas.
Cherepanov SA; Cherepanova KI; Grinenko NF; Antonova OM; Chekhonin VP
Bull Exp Biol Med; 2016 Sep; 161(5):674-678. PubMed ID: 27709388
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.
Ulasov IV; Nandi S; Dey M; Sonabend AM; Lesniak MS
Mol Med; 2011; 17(1-2):103-12. PubMed ID: 20957337
[TBL] [Abstract][Full Text] [Related]
4. Cyclopamine treatment of human embryonic stem cells followed by culture in human astrocyte medium promotes differentiation into nestin- and GFAP-expressing astrocytic lineage.
Lee DS; Yu K; Rho JY; Lee E; Han JS; Koo DB; Cho YS; Kim J; Lee KK; Han YM
Life Sci; 2006 Dec; 80(2):154-9. PubMed ID: 17028036
[TBL] [Abstract][Full Text] [Related]
5. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma.
Bar EE; Chaudhry A; Lin A; Fan X; Schreck K; Matsui W; Piccirillo S; Vescovi AL; DiMeco F; Olivi A; Eberhart CG
Stem Cells; 2007 Oct; 25(10):2524-33. PubMed ID: 17628016
[TBL] [Abstract][Full Text] [Related]
6. Cyclopamine sensitizes glioblastoma cells to temozolomide treatment through Sonic hedgehog pathway.
Carballo GB; Matias D; Ribeiro JH; Pessoa LS; Arrais-Neto AM; Spohr TCLSE
Life Sci; 2020 Sep; 257():118027. PubMed ID: 32622951
[TBL] [Abstract][Full Text] [Related]
7. Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinoma.
Tsai CL; Hsu FM; Tzen KY; Liu WL; Cheng AL; Cheng JC
J Gastroenterol Hepatol; 2015 Aug; 30(8):1317-24. PubMed ID: 25682950
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance.
Huang FT; Zhuan-Sun YX; Zhuang YY; Wei SL; Tang J; Chen WB; Zhang SN
Int J Oncol; 2012 Nov; 41(5):1707-14. PubMed ID: 22923052
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells.
Elamin MH; Shinwari Z; Hendrayani SF; Al-Hindi H; Al-Shail E; Khafaga Y; Al-Kofide A; Aboussekhra A
Mol Carcinog; 2010 Mar; 49(3):302-14. PubMed ID: 20025076
[TBL] [Abstract][Full Text] [Related]
10. Cyclopamine bioactivity by extraction method from Veratrum californicum.
Turner MW; Cruz R; Mattos J; Baughman N; Elwell J; Fothergill J; Nielsen A; Brookhouse J; Bartlett A; Malek P; Pu X; King MD; McDougal OM
Bioorg Med Chem; 2016 Aug; 24(16):3752-7. PubMed ID: 27338657
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines.
Ferruzzi P; Mennillo F; De Rosa A; Giordano C; Rossi M; Benedetti G; Magrini R; Pericot Mohr Gl; Miragliotta V; Magnoni L; Mori E; Thomas R; Tunici P; Bakker A
Int J Cancer; 2012 Jul; 131(2):E33-44. PubMed ID: 22072503
[TBL] [Abstract][Full Text] [Related]
12. Expression of sonic hedgehog signaling components in hepatocellular carcinoma and cyclopamine-induced apoptosis through Bcl-2 downregulation in vitro.
Chen XL; Cheng QY; She MR; Wang Q; Huang XH; Cao LQ; Fu XH; Chen JS
Arch Med Res; 2010 Jul; 41(5):315-23. PubMed ID: 20851287
[TBL] [Abstract][Full Text] [Related]
13. The sonic hedgehog signaling pathway stimulates anaplastic thyroid cancer cell motility and invasiveness by activating Akt and c-Met.
Williamson AJ; Doscas ME; Ye J; Heiden KB; Xing M; Li Y; Prinz RA; Xu X
Oncotarget; 2016 Mar; 7(9):10472-85. PubMed ID: 26859575
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma.
El Khatib M; Kalnytska A; Palagani V; Kossatz U; Manns MP; Malek NP; Wilkens L; Plentz RR
Hepatology; 2013 Mar; 57(3):1035-45. PubMed ID: 23172661
[TBL] [Abstract][Full Text] [Related]
15. Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance.
Shahi MH; Farheen S; Mariyath MP; Castresana JS
Tumour Biol; 2016 Nov; 37(11):15107-15114. PubMed ID: 27662839
[TBL] [Abstract][Full Text] [Related]
16. Hedgehog targeting by cyclopamine suppresses head and neck squamous cell carcinoma and enhances chemotherapeutic effects.
Mozet C; Stoehr M; Dimitrova K; Dietz A; Wichmann G
Anticancer Res; 2013 Jun; 33(6):2415-24. PubMed ID: 23749890
[TBL] [Abstract][Full Text] [Related]
17. Astrocytes Decreased the Sensitivity of Glioblastoma Cells to Temozolomide and Bay 11-7082.
Pustchi SE; Avci NG; Akay YM; Akay M
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998285
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cytotoxic properties of a cyclopamine glucuronide prodrug in rat glioblastoma cells and tumors.
Bensalma S; Chadeneau C; Legigan T; Renoux B; Gaillard A; de Boisvilliers M; Pinet-Charvet C; Papot S; Muller JM
J Mol Neurosci; 2015 Jan; 55(1):51-61. PubMed ID: 25280457
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of inhibitors of Hedgehog signaling based on the alkaloid cyclopamine.
Winkler JD; Isaacs A; Holderbaum L; Tatard V; Dahmane N
Org Lett; 2009 Jul; 11(13):2824-7. PubMed ID: 19552464
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation.
Liu YJ; Ma YC; Zhang WJ; Yang ZZ; Liang DS; Wu ZF; Qi XR
Oncotarget; 2017 Jun; 8(26):42495-42509. PubMed ID: 28477008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
